Changes in Clinical Manifestations Due to AFLD Retyping Based on the New MAFLD Criteria: An Observational Study Based on the National Inpatient Sample Database

Feng, XS; Xuan, RR; Dong, YC; Wu, XQ; Cheng, YP; Yuan, ZN; Dong, H; Han, JM; Zhong, F; Zhao, JJ; Fan, XD

Zhao, JJ; Fan, XD (通讯作者),Shandong First Med Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250021, Peoples R China.;Zhao, JJ; Fan, XD (通讯作者),Shandong Clin Res Ctr Diabet & Metab Dis, Jinan 250021, Peoples R China.;Zhao, JJ; Fan, XD (通讯作者),Shandong Inst Endocrine & Metab Dis, Jinan 250021, Peoples R China.;Zhao, JJ; Fan, XD (通讯作者),Shandong Engn Lab Prevent & Control Endocrine & Me, Jinan 250021, Peoples R China.;Zhao, JJ; Fan, XD (通讯作者),Shandong Engn Res Ctr Stem Cell & Gene Therapy End, Jinan 250021, Peoples R China.

DIAGNOSTICS, 2023; 13 (3):

Abstract

(1) Background: As the introduction of positive diagnostic criteria for metabolic dysfunction-associated fatty liver disease (MAFLD) does not exclude ......

Full Text Link